UA93135C2 - КРИСТАЛІЧНА ФОРМА ГЕМІГІДРАТУ 1-(β-D-ГЛЮКОПІРАНОЗИЛ)-4-МЕТИЛ-3-[5-(4-ФТОРФЕНІЛ)-2-ТІЕНІЛМЕТИЛ]БЕНЗОЛУ - Google Patents

КРИСТАЛІЧНА ФОРМА ГЕМІГІДРАТУ 1-(β-D-ГЛЮКОПІРАНОЗИЛ)-4-МЕТИЛ-3-[5-(4-ФТОРФЕНІЛ)-2-ТІЕНІЛМЕТИЛ]БЕНЗОЛУ

Info

Publication number
UA93135C2
UA93135C2 UAA200906994A UAA200906994A UA93135C2 UA 93135 C2 UA93135 C2 UA 93135C2 UA A200906994 A UAA200906994 A UA A200906994A UA A200906994 A UAA200906994 A UA A200906994A UA 93135 C2 UA93135 C2 UA 93135C2
Authority
UA
Ukraine
Prior art keywords
thienylmethyl
glucopyranosyl
fluorophenyl
methyl
crystalline form
Prior art date
Application number
UAA200906994A
Other languages
English (en)
Russian (ru)
Inventor
Суміхіро Номура
Ейджі Каваніші
Original Assignee
Міцубісі Танабе Фарма Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Міцубісі Танабе Фарма Корпорейшн filed Critical Міцубісі Танабе Фарма Корпорейшн
Priority claimed from PCT/JP2007/073729 external-priority patent/WO2008069327A1/en
Publication of UA93135C2 publication Critical patent/UA93135C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/04—Carbocyclic radicals

Abstract

Нова кристалічна форма гемігідрату 1-((-D-глюкопіранозил)-4-метил-3-[5-(4-фторфеніл)-2-тіенілметил]бензолу.
UAA200906994A 2006-12-04 2007-12-03 КРИСТАЛІЧНА ФОРМА ГЕМІГІДРАТУ 1-(β-D-ГЛЮКОПІРАНОЗИЛ)-4-МЕТИЛ-3-[5-(4-ФТОРФЕНІЛ)-2-ТІЕНІЛМЕТИЛ]БЕНЗОЛУ UA93135C2 (uk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86842606P 2006-12-04 2006-12-04
JP2006327019 2006-12-04
PCT/JP2007/073729 WO2008069327A1 (en) 2006-12-04 2007-12-03 CRYSTALLINE FORM OF 1- (β-D-GLUCOPYRANOSYL) -4 -METHYL- 3- [5- (4 -FLUOROPHENYL) -2-THIENYLMETHYL] BENZENE HEMIHYDRATE

Publications (1)

Publication Number Publication Date
UA93135C2 true UA93135C2 (uk) 2011-01-10

Family

ID=50486662

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200906994A UA93135C2 (uk) 2006-12-04 2007-12-03 КРИСТАЛІЧНА ФОРМА ГЕМІГІДРАТУ 1-(β-D-ГЛЮКОПІРАНОЗИЛ)-4-МЕТИЛ-3-[5-(4-ФТОРФЕНІЛ)-2-ТІЕНІЛМЕТИЛ]БЕНЗОЛУ

Country Status (3)

Country Link
HR (1) HRP20140254T4 (uk)
NI (1) NI200900113A (uk)
UA (1) UA93135C2 (uk)

Also Published As

Publication number Publication date
NI200900113A (es) 2010-11-29
HRP20140254T4 (hr) 2021-10-29
HRP20140254T1 (en) 2014-04-25

Similar Documents

Publication Publication Date Title
MY153702A (en) Crystalline form of 1-(b-d-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate
EA200802119A1 (ru) Новая кристаллическая форма vi агомелатина, способ его получения и фармацевтические композиции, которые ее содержат
RS51954B (en) CRYSTAL MODIFICATIONS OF PYRACLOSTROBIN
EA200601271A1 (ru) Новая кристаллическая форма iv агомелатина, способ её получения и фармацевтические композиции, которые её содержат
MY142108A (en) CRYSTALLINE FORM OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
EA200601273A1 (ru) Новая кристаллическая форма v агомелатина, способ её получения и фармацевтические композиции, которые её содержат
IL204145A (en) Processes for the preparation of sglt inhibitors, crystalline forms of 1– (d – β ––– glucopyranosyl) –4 – chloro – 3– [5– (6-fluoro-3-pyridyl) –2-thienylmethyl] benzene, pharmaceutical preparations containing them and uses In them
EA200601274A1 (ru) Новая кристаллическая форма iii агомелатина, способ её получения и фармацевтические композиции, которые её содержат
TW200745149A (en) Crystalline form of 1'-(1-methylethyl)-4'-[(2-fluoro-4-methoxyphenyl)methyl]-5'-methyl-1H-pyrazol-3'-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments
NZ591027A (en) Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
WO2009115655A3 (fr) Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
EP2032715A4 (en) METHODS AND MATERIALS FOR THE PREPARATION OF SIMVASTATIN AND ITS COMPOUNDS
CU23774A3 (es) Inhibición de arni de expresión de alfa-enac
TW200731999A (en) Taste masking of essential oils using a hydrocolloid
HRP20110641T1 (en) Crystalline modification of fipronil
RS53057B (en) NEW CRYSTAL FORM 3- (difluoromethyl) -1-methyl-N- (3`, 4`, 5`-trifluoro [1,1`-biphenyl] -2-yl) -1H-pyrazole-4-carboxamide
MX2007010143A (es) Formas cristalinas de intermedio de linezolid.
MX2009004947A (es) Arilsulfonil-pirrolidinas como inhibidores 5-hidroxitriptaminas6 (5-ht6).
UA93135C2 (uk) КРИСТАЛІЧНА ФОРМА ГЕМІГІДРАТУ 1-(β-D-ГЛЮКОПІРАНОЗИЛ)-4-МЕТИЛ-3-[5-(4-ФТОРФЕНІЛ)-2-ТІЕНІЛМЕТИЛ]БЕНЗОЛУ
WO2008098143A3 (en) Antimicrobial compounds and methods of use
EA200900936A1 (ru) Аморфные и кристаллические формы ривастигмина гидротартрата
JO3523B1 (ar) صورة متبلرة من نصف هيدرات 1(b-d- جلوكو بيرانوسيل)-4-ميثيل-3-[ 5-(4-قلورو فينيل) -2-ثنيينيل ميثيل]بترين
CY1114969T1 (el) ΚΡΥΣΤΑΛΛΙΚΗ ΜΟΡΦΗ ΗΜΙΕΝΥΔΡΟΥ 1- (β-D-ΓΛΥΚΟΠΥΡΑΝΟΖΥΛΟ) -4 -ΜΕΘΥΛΟ- 3- [5- (4-ΦΘΟΡΟΦΑΙΝΥΛΟ)-2- ΘΕΙΕΝΥΛΟΜΕΘΥΛΟ]ΒΕΝΖΟΛΙΟΥ
TW200640854A (en) Methods of making pravastatin sodium
RS51231B (sr) Antitumorska kombinacija koja sadrži derivate substituisanog akriloil distamicina i antitela koja inhibiraju faktore rasta ili njihove receptore